Similar articles

• Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.

  Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS. Stephenson A, et al. Arch Intern Med. 2011 May 23;171(10):914-20. doi: 10.1001/archinternmed.2011.170. Arch Intern Med. 2011. PMID: 21606096
• Inhaled anticholinergic drugs and risk of acute urinary retention.

  Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG. Afonso AS, et al. BJU Int. 2011 Apr;107(8):1265-72. doi: 10.1111/j.1464-410X.2010.09600.x. Epub 2010 Sep 29. BJU Int. 2011. PMID: 20880196
• Photosensitive lichenoid eruption and inhaled tiotropium bromide.

  Pérez-Pérez L, Cabanillas M, Pereiro Ferreirós MM, Peteiro C, Toribio J. Pérez-Pérez L, et al. Dermatology. 2007;214(1):97-8. doi: 10.1159/000096922. Dermatology. 2007. PMID: 17191057 No abstract available.
• The cardiovascular risk of tiotropium: is it real?

  Cazzola M, Calzetta L, Matera MG. Cazzola M, et al. Expert Opin Drug Saf. 2010 Sep;9(5):783-92. doi: 10.1517/14740338.2010.500611. Expert Opin Drug Saf. 2010. PMID: 20565229 Review.
• Anticholinergic treatment in airways diseases.

  Flynn RA, Glynn DA, Kennedy MP. Flynn RA, et al. Adv Ther. 2009 Oct;26(10):908-19. doi: 10.1007/s12325-009-0074-x. Epub 2009 Nov 27. Adv Ther. 2009. PMID: 19967500 Review.